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Abstract 
Mushrooms are widely appreciated for their organoleptic qualities, being also 
recognized as good sources of bioactive compounds that provide antioxidant, 
antimicrobial and cytotoxic activities. Polysaccharides (including glucans) are often 
pointed out as the most bioactive compounds isolated from mushrooms, but other 
molecules such as triterpenoids, might also be highlighted for their bioactivity. In 
scientific research, when isolated compounds are used, potential synergistic effects 
might be lost. Accordingly, the bioactivity of P. linteus was evaluated in selected 
fractions (polysaccharides, glucans and triterpenoids), as well as in the methanolic and 
ethanolic extracts. The best antioxidant and antibacterial activities were obtained with 
methanolic extract, while glucan and triterpenoid fractions gave the strongest antifungal 
activity. In contrast, ethanolic extract gave the best results in cytotoxic activity, 
indicating that the bioactive compounds present might act synergistically. The 
differentiated activity of P. linteus fractions and extracts could be useful to find 
antimicrobial, antioxidant and cytotoxic agents as alternatives to synthetic chemicals 
with application in agriculture, food industry or pharmacy. 
 
Keywords: Phellinus linteus; bioactive compounds; antioxidant; antimicrobial; 
cytotoxic. 
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1. Introduction 
Wild mushrooms contain different bioactive compounds such as phenolic compounds, 
tocopherols and ascorbic acid, which could be extracted for the purpose of being used as 
functional ingredients namely against chronic diseases related to oxidative stress. Also, 
mushrooms might be used directly in diet and promote health, taking advantage of the 
additive and synergistic effects of their bioactive compounds (Ferreira, Barros, & 
Abreu, 2009).  
Phellinus linteus, originally described as Polyporus linteus (Kim, Kim, Sung, & 
Harrington, 1999), belongs to the Hymenochaetaceae family (Basidiomycetes) and has 
long been used for the treatment of stomachache, inflammation, arthritis of the knee, 
gastrointestinal disorder, non-insulin-dependent diabetes, lymphatic disease and cancer 
(Huang et al., 2011; Kim et al., 2004a). It was previously described as 
immunomodulatory (Wu, Liaw, Pan, Yang, & Ng, 2013), neuroprotective (Chen, Feng, 
Huang, & Su, 2012), antitumor (Zhu et al., 2007; Huang et al., 2011; Song et al., 2011), 
anti-hepatotoxic (Kim et al., 2004b), antioxidant (Ferreira et al., 2009), anti-angiogenic 
and anti-inflammatory (Kim et al., 2004a). P. linteus was also reported as having 
antimicrobial activity, especially against Bacillus cereus and methicillin-resistant 
Staphylococcus aureus (Alves et al., 2012; Hur et al., 2004). Several P. linteus 
secondary metabolites were previously isolated like lectines, triterpenes (Maiti et al., 
2010), meshimakobnols A and B (Nagatsu et al., 2004), hispidin (Lee et al., 2008; Chen 
et al., 2012), davallialactone, methyldavallialactone, hypholomine B, interfungins A, 
inoscavin A, protocatechuic acid, protocatechualdehyde, caffeic acid, ellagic acid (Lee 
et al., 2008), and also phellifuropyranone A, phelligridin G (Kojima, Ohno, Inoue, 
Mizukami, & Nagatsu, 2008) and phelligridimer A (Lee et al., 2008). Nevertheless, 
polysaccharides (particularly β-D-glucans and polysaccharopeptides (PSP)) are the best 
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known and most potent mushroom-derived substances with antitumor and 
immunomodulating properties, stimulating humoral and cell-mediated immunity 
(Ferreira, Vaz, Vasconcelos, & Martins, 2010; Maiti et al., 2010; Heleno et al., 2012). 
The biological activities of triterpenoids are also relevant, progressively receiving more 
attention in the biochemical and medical fields due to their immunomodulatory and 
antitumor effects (Tu, Sun, & Ye, 2008).  
Herein, the composition in hydrophilic (free sugars, organic acids and phenolic acids) 
and lipophilic (ergosterol, tocopherols and fatty acids) compounds was evaluated in P. 
linteus, as well as their antioxidant, antibacterial and antifungal properties, and 
cytotoxicity in human tumor cell lines. Instead of evaluating individual compounds, the 
whole methanolic and ethanolic extracts as also different fractions (polysaccharides, 
glucans and triterpenoids) were used, allowing evaluating potential synergistic 
activities.  
 
2. Material and Methods 
 
2.1. Samples, extract and fractions preparation 
Crude material (dry fruiting body) and crude fractions of polysaccharides and 
triterpenoids of wild Phellinus linteus are commercial food supplements and were 
kindly provided by Amazing Grace Health Industries (Bangkok, Thailand). Glucans 
were semi purified from P. linteus polysaccharides as described before (Song, Helsper, 
& Van Griensven, 2008) by repeated precipitation in 65% ethanol to remove the excess 
mannitol and ethanol-soluble phenolic compounds. The precipitate was dried at 42º C, 
in vacuum and stored for further use. 
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The methanolic extract was obtained by stirring the dry fruiting body (1 g) with 40 mL 
of methanol for 1 h and subsequently filtered through Whatman No. 4 paper. The 
residue was then extracted with 20 mL of methanol for 1 h. The combined methanolic 
extracts were evaporated at 40ºC (rotary evaporator Büchi R-210) to dryness. 
The ethanolic extract was obtained from dry fruiting body by extraction with 90% 
ethanol during 48 h at 70º C. The extract (probably rich in triterpenoids and 
polyphenols) was filtrated and centrifuged to get a clear liquid, and finally evaporated at 
low pressure at 40º C.   
 
2.2. Standards and reagents 
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade from 
Fisher Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) reference 
standard mixture 37 (standard 47885-U) was purchased from Sigma (St. Louis, MO, 
USA), as also other individual fatty acid isomers and standards of tocopherols, 
ergosterol, sugars, organic acids and phenolic compounds, and trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid). Racemic tocol, 50 mg/mL, was 
purchased from Matreya (PA, USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was 
obtained from Alfa Aesar (Ward Hill, MA, USA). Mueller-Hinton agar (MH) and malt 
agar (MA) were obtained from the Institute of Immunology and Virology, Torlak 
(Belgrade, Serbia). Dimethylsulfoxide (DMSO), (Merck KGaA, Germany) was used as 
a solvent. Phosphate buffered saline (PBS) was obtained from Sigma Chemical Co. (St. 
Louis, USA). Foetal bovine serum (FBS), L-glutamine, Hank’s balanced salt solution 
(HBSS), trypsin-EDTA (ethylenediamine tetraacetic acid), nonessential amino acids 
solution (2 mM), penicillin/streptomycin solution (100 U/mL and 100 mg/mL, 
respectively), RPMI-1640 and DMEM media were from Hyclone (Logan, USA). Acetic 
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acid, ellipticine, sulforhodamine B (SRB), trypan blue, trichloroacetic acid (TCA) and 
Tris were from Sigma Chemical Co. (Saint Louis, USA). Methanol and all other 
chemicals and solvents were of analytical grade and purchased from common sources. 
Water was treated in a Milli-Q water purification system (TGI Pure Water Systems, 
USA).  
 
2.3. Chemical characterization of Phellinus linteus 
2.3.1. Macronutrients 
The samples were analysed for chemical composition (moisture, proteins, fat, 
carbohydrates and ash) using the AOAC procedures (AOAC, 1995). The crude protein 
content (N×4.38) of the samples was estimated by the macro-Kjeldahl method; the 
crude fat was determined by extracting a known weight of powdered sample with 
petroleum ether, using a Soxhlet apparatus; the ash content was determined by 
incineration at 600±15 ºC. Total carbohydrates were calculated by difference. Energy 
was calculated according to the following equation: Energy (kcal) = 4 × (g protein + g 
carbohydrate) + 9 × (g fat). 
 
2.3.2. Hydrophilic compounds 
Free sugars.  Sugars were analysed by high performance liquid chromatography 
(HPLC) using a refraction index (RI) detector. This assay was conducted according to a 
previously described methodology (Reis et al., 2013).  
 
Organic acids. Organic acids were analyzed by ultra-fast liquid chromatography 
(UFLC) coupled to a photodiode array detector (PDA) following a previously described 
procedure (Reis et al., 2013). The organic acids were quantified by comparison of the 
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peak area recorded at 215 nm with calibration curves calculated from commercial 
standards of each compound. The results were expressed in g per 100 g of dry weight. 
 
Phenolic acids. The analysis was performed by the same HPLC equipment described 
for organic acids, according to a previously described procedure (Reis et al., 2013). 
Detection was carried out in a PDA using 280 nm as the preferred wavelength.  
 
2.3.3. Lipophilic compounds 
Fatty acids. Fatty acids were determined by gas-liquid chromatography with flame 
ionization detection (GC-FID)/capillary column as described previously (Reis et al., 
2012a). Split injection (1:40) was carried out at 250 ºC. Fatty acids identification was 
made by comparing the relative retention times of FAME peaks from samples with 
standards. The results were recorded and processed using the Clarity DataApex 4.0 
Software and expressed in relative percentage of each fatty acid. 
	  
Tocopherols. The analysis were carried out using the HPLC equipment described above 
coupled to a fluorescence detector (FP-2020; Jasco) programmed for excitation at 290 
nm and emission at 330 nm according to a previously described methodology (Heleno, 
Barros, Sousa, Martins, & Ferreira, 2010). The compounds were identified by 
chromatographic comparisons with authentic standards. Quantification was based on the 
fluorescence signal response of each standard, using the IS (tocol) method and by using 
calibration curves obtained from commercial standards of each compound. The results 
were expressed in µg per 100 g of dry weight. 
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Ergosterol. Sterols were extracted using a previously optimized multi-step procedure 
(Barreira, Oliveira, & Ferreira, 2013). The analyses were performed in the HPLC 
equipment (described above) coupled to an ultraviolet Smartline 2500 UV detector. 
Ergosterol was quantified by comparison of the area of its peak with the calibration 
curve obtained from a commercial standard. Cholecalciferol was used as internal 
standard. The results were expressed in mg per g of fat, mg per 100 g of dry weight and 
mg per 100 g of fresh weight. 
 
2.4. Evaluation of the antioxidant activity of different fractions and extracts of P. linteus  
The fractions/extracts were re-dissolved in water:DMSO at 20 mg/mL. Successive 
dilutions from the stock solution were made and submitted to in vitro assays already 
described by Reis et al. (2012b). Four different assays were performed: reducing power, 
DPPH radical-scavenging activity, inhibition of β-carotene bleaching or β-
carotene/linoleate assay and thiobarbituric acid reactive substances (TBARS) assay 
The sample concentrations (mg/mL) providing 50% of antioxidant activity or 0.5 of 
absorbance (EC50) were calculated from the graphs of antioxidant activity percentages 
(DPPH, β-carotene/linoleate and TBARS assays) or absorbance at 690 nm 
(ferricyanide/Prussian blue assay) against sample concentrations. Trolox was used as a 
positive control. 
 
2.5. Evaluation of the antimicrobial activity of different fractions and extracts of P. 
linteus 
The fractions/extracts were re-dissolved in 5% solution of DMSO in distilled water at 
100 mg/mL. Successive dilutions were made from the stock solution and submitted to 
antibacterial and antifungal assays. 
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2.5.1. Antibacterial activity 
The assayed Gram-negative bacteria species were obtained from the Mycological 
laboratory, Department of Plant Physiology, Institute for biological research “Sinisa 
Stanković”, University of Belgrade, Serbia. The antibacterial activity evaluation was 
performed according to a previously described methodology (Reis et al., 2013).  
The minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were 
determined by the microdilution method (Espinel-Ingroff, 2001). The minimum 
inhibitory concentrations (MICs) obtained from the susceptibility testing of various 
bacteria to tested extract/fraction were determined also by a colorimetric microbial 
viability assay based on reduction of INT color and compared with positive control for 
each bacterial strains (CSLI, 2006; Tsukatani et al., 2012). MBC was determined by 
serial sub-cultivation of 10 µL into microplates containing 100 µL of TSB. The lowest 
concentration that shows no growth after this sub-culturing was read as the MBC. 
Standard drugs, namely streptomycin and ampicillin were used as positive controls. 
DMSO (5%) was used as negative control. 
 
2.5.2. Antifungal activity  
For the antifungal bioassays, the microfungi were obtained from the Mycological 
Laboratory, Department of Plant Physiology, Institute for Biological Research “Siniša 
Stanković”, Belgrade, Serbia.	 The micromycetes were maintained on malt agar (MA) 
and the cultures were stored at +4 °C and subcultured once a month (Booth, 1971). The 
microfungi cultures were established as previously described (Reis et al., 2013). 
Minimum inhibitory concentrations (MICs) were determined by a serial dilution 
technique using 96-well microtitre plates. The fractions/extracts were dissolved in 5% 
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solution of DMSO and added to broth malt medium with fungal inoculum. The 
microplates were incubated for 72 h at 28 °C. The lowest concentrations without visible 
growth (at the binocular microscope) were defined as MIC. The minimum fungicidal 
concentrations (MFCs) were determined by serial subcultivation of 2 µL in microtitre 
plates containing 100 µL of malt broth per well and further incubation for 72 h at 28 °C. 
The lowest concentration with no visible growth was defined as the MFC, indicating 
99.5% killing of the original inoculum. Bionazole and ketokonazole were used as 
positive controls. DMSO (5%) was used as negative control. 
 
2.6. Evaluation of the anti-proliferative activity of the fractions and extracts of P. 
linteus 
The fractions/extracts were re-dissolved in water:DMSO at 8 mg/mL. Successive 
dilutions were made from the stock solution and tested against five human tumor cell 
lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HCT-
15 (colon carcinoma), HeLa (cervical carcinoma) and HepG2 (hepatocellular 
carcinoma). Cells were routinely maintained as adherent cell cultures (Reis et al., 2013). 
Cells were treated for 48h with the diluted fraction/extract solutions. The adherent cells 
were ﬁxed by adding cold 10% trichloroacetic acid (TCA, 100 µL) and incubated for 60 
min at 4 ºC. Plates were then washed with deionized water and dried; sulforhodamine B 
solution (0.1% in 1% acetic acid, 100 µL) was then added to each plate well and 
incubated for 30 min at room temperature. Unbound SRB was removed by washing 
with 1% acetic acid. Plates were air dried, the bound SRB was solubilised with 10 mM 
Tris (200 µl, pH 7.4) and the absorbance was measured at 540 nm (Monks et al., 1991). 
The results were expressed in GI50 values (sample concentration that inhibited 50% of 
the net cell growth). Ellipticine was used as positive control. 
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2.7. Evaluation of hepatotoxicity of fractions and extracts of P. linteus 
An hepatic cell, designed as PLP2, was used (Abreu et al., 2011). Cells were treated for 
48h with the different diluted sample solutions and the same procedure described in the 
previous section for SRB assay was followed. The results were expressed in GI50 values 
(sample concentration that inhibited 50% of the net cell growth). Ellipticine was used as 
positive control. 
 
2.8. Statistical analysis 
All analyses (fractions and extracts) were performed in triplicate; each replicate was 
quantified also three times. Data were expressed as mean±standard deviation.  
The fulfillment of the one-way ANOVA requirements, specifically the normal 
distribution of the residuals and the homogeneity of variance, was tested by means of 
the Shapiro-Wilk’s (and also, due to the low size of samples, by direct observation of 
the normal Q-Q plots), and the Levene’s tests, respectively. In the cases where statistical 
significance differences were identified, the dependent variable were compared using 
Tukey’s honestly significant difference (HSD) or Tamhane’s T2 multiple comparison 
tests, when homoscedasticity was verified or not, respectively. 
 
3. Results and Discussion 
The results obtained for macronutrients and lipophilic compounds quantification are 
presented in Table 1. The hydrophilic compounds were not tabled since any individual 
sugars or phenolic acids could be detected. Even in what concerns organic acids, oxalic 
acid was the only detected molecule (0.295 g/100 g dw). Carbohydrates were the major 
macronutrient (95.4 g/100 g dw), followed by protein (2.8 g/100 g dw) and ash (1.3 
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g/100 g dw). As it is common on this kind of natural matrix, fat content was quite low 
(0.49 g/100 g dw). Despite this profile, energy was relatively high (397.2 g/100 g dw). 
The main fatty acids (FA) were palmitic acid (C16:0), linoleic acid (C18:2n6), oleic 
acid (C18:1n9) and stearic acid (C18:0) (Table 1), showing some similarity to 
previously published data on P. linteus from other location (Deng et al., 2011). 
Saturated fatty acids (SFA) predominated (58.3% of total FA) over unsaturated fatty 
acids (UFA) (monounsaturated: 14.6% of total FA; polyunsaturated: 27.1% of total 
FA), but this is not relevant in terms of dietary intake, considering the low fat amounts 
of this species.  
Regarding vitamin E profile, two isoforms were detected: α- and γ-tocopherol. Despite 
the limitation comprised by the fat content, the quantified vitamin E levels might be 
considered interesting, especially due to its role as peroxidation breaker or protectors of 
the integrity of lipid structures, since tocopherols are found in plasma, red cells and 
tissues (Burton & Traber, 1990).  
Ergosterol was also quantified, revealing low values (2.73 mg/100 g dw) when 
compared with other wild and cultivated species (Barreira et al., 2013). Nevertheless, 
the presence of this vitamin precursor, known for health-promoting properties such as 
antioxidant, anti-inflammatory, antihyperlipidemic or immunomodulating activities 
(Barreira et al., 2013), is always relevant.   
Considering the performed bioactivity assays, from the analysis of the results for the 
antioxidant potential (Table 2), it might be concluded that the methanolic extract of P. 
linteus revealed the lowest EC50 values for DPPH radical-scavenging activity (70 
µg/mL), reducing power (50.5 µg/mL) and lipid peroxidation inhibition, either for β-
carotene bleaching inhibition (114 µg/mL) as well as for TBARS inhibition (8 µg/mL). 
Among the assayed fractions, glucans showed the lowest antioxidant activity. The 
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highest activity among assays was obtained for TBARS formation inhibition, while the 
worst values resulted from β-carotene bleaching inhibition. Nevertheless, P. linteus 
proved to have high potential for antioxidant purposes, since the obtained EC50 values 
were lower than those resulting from other wild edible species, which varied from 20.02 
to 0.68 mg/mL (Pereira, Barros, Martins, & Ferreira, 2012). In a previous study, P. 
linteus was shown to scavenge directly the DPPH radical over a concentration range of 
10 µg/mL (30% inhibition) to 300 µg/mL (85% inhibition), suggesting that the stable 
free radical scavenging activity of P. linteus is comparable to that of vitamin C (Song et 
al., 2003). In the same study, P. linteus and butylated hydroxyanisole, an inhibitor of 
lipid peroxidation (LPO), were evaluated for the inhibition of LPO in rat brain 
homogenate, initiated by FeCl2, showing that P. linteus reduced LPO in a concentration-
dependent manner at concentrations ranging from 10 to 300 µg/mL with an IC50 of 
48.45 µg/mL (Song et al., 2003), i.e., nearly 6 times weaker than the value herein 
reported using brain homogenates.  
Concerning the antibacterial activity (Table 3), the methanolic extract also revealed the 
highest potential, considering MIC or MBC values, almost in all cases; moreover, it 
gave higher activity (in line with ethanolic extract) than ampicillin for all bacteria, and 
than streptomycin (except in the case of Staphylococcus aureus). The glucans fraction 
was the less effective against bacterial growth, except in the case of Salmonella 
typhimurium.  
Regarding the antifungal activity (Table 4), the results were quite dissimilar, since 
methanolic extract had the highest activity only against Trichoderma viride (MIC = 
0.0045 mg/mL; MBC = 0.013 mg/mL) and Penicillium ochrochloron (MIC = 0.20 
mg/mL; MBC = 0.38 mg/mL). Furthermore, the fractions with highest antifungal 
activity were glucans and triterpenoids (which were actually the least effective against 
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bacteria), presenting lower MIC and MBC values than bifonazole and ketoconazole on 
Aspergillus versicolor, Aspergillus ochraceus, Trichoderma viride and Penicillium 
funiculosum. Aspergillus versicolor, Aspergillus ochraceus and Trichoderma viride 
(MIC  ≤ 0.27 mg/mL; MFC ≤ 0.77 mg/mL, for all samples) were the fungal species 
with highest susceptibility to P. linteus.  
The results obtained for cytotoxic activity in human tumor cell lines are presented in 
Table 5. The lowest GI50 values were obtained for ethanolic extract in all cell lines 
except HepG2, which proved to be more sensitive to the polysaccharidic fraction (97 
µg/mL). Polysaccharides from P. linteus already exhibited antiproliferative effect in 
human hepatoma cells, specifically in Bel-7404 and in the same line used herein 
(OuYang et al., 2013). The ethanolic extract was particularly active on human non-
small cell lung human (NCI-H460; 88 µg/mL), colon (HCT-15; 62 µg/mL) and cervical 
(HeLa; 61 µg/mL) carcinoma cell lines. At the mentioned concentrations, the different 
fractions and extracts did not show toxicity against non-tumor liver primary cells 
(PLP2; GI50 > 400 µg/mL). The presented results clearly indicate that the 
antiproliferative activity of P. linteus might be significantly improved using an ethanol 
extract  (certainly rich in triterpenoids and polyphenols) instead of polysaccharides 
fraction. 
 
Overall, this study provided relevant knowledge regarding chemical and bioactive 
compounds profile of the medicinal mushroom Phellinus linteus. Despite the low 
number of detected hydrophilic compounds, P. linteus proved its high bioactivity, as 
measured by antioxidant, antibacterial and cytotoxic assays (in different human tumor 
cell lines). The whole methanolic and ethanolic extracts, and different fractions 
(polysaccharides, glucans and triterpenoids) were assayed, showing a differentiated 
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mode of action regarding each of the evaluated bioactivities. The methanolic extract 
showed the highest antioxidant and antibacterial activities; glucan and triterpenoid 
fractions had the best antifungal activity; ethanolic extract gave the best results on 
cytotoxic activity, indicating that the bioactive compounds present (certainly 
triterpenoids and polyphenols) might act synergistically. The antimicrobial and 
cytotoxic activities of P. linteus justifies further studies to find antibacterial and 
antifungal agents as alternatives to synthetic chemicals applied in agriculture, food 
industry or pharmacy, as also to establish P. linteus as a promising source for 
developing new generation anticancer drugs. 
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Table 1. Composition of Phellinus linteus in macronutrients and lipophilic compounds 
(mean±SD). 
dw- dry weight. Caproic acid (C6:0); Caprylic acid (C8:0); Capric acid (C10:0); Lauric acid (C12:0); 
Myristic acid (C14:0); Pentadecanoic acid (C15:0); Palmitic acid (C16:0); Palmitoleic acid (C16:1); 
Heptadecanoic acid (C17:0); Stearic acid (C18:0); Oleic acid (C18:1n9c); Linoleic acid (C18:2n6c); α-
Linolenic acid (C18:3n3); Arachidic acid (C20:0); Arachidonic acid methyl ester (C20:3n6); Behenic acid 
(C22:0); Erucic acid (C22:1n9); Tricosanoic acid (C23:0); Lignoceric acid (C24:0). SFA- saturated fatty 
acids; MUFA- monounsaturated fatty acids; PUFA- polyunsaturated fatty acids. 
 
 
Macronutrients 
Ash 
(g/100 g dw) 
Proteins 
(g/100 g dw) 
Fat 
(g/100 g dw) 
Carbohydrates 
(g/100 g dw) 
Energy 
(kcal/100 g dw) 
1.3±0.1  2.8±0.3 0.49±0.03 95.4±0.4 397.2± 0.2 
Lipophilic compounds 
Tocopherols (µg/100 g DW) Fatty acids (relative %) 
α-Tocopherol  27±1 C6:0 0.19±0.02 
γ-Tocopherol 20±2 C8:0 0.39±0.01 
Total tocopherols 47±2 C10:0 0.19±0.01 
Ergosterol (mg/100 g DW) 2.73±0.02 C12:0 0.54±0.02 
 C14:0 1.58±0.02 
 C15:0 1.07±0.04 
 C16:0 26.8±0.2 
 C16:1 0.37±0.03 
 C17:0 2.37±0.02 
 C18:0 12.3±0.1 
 C18:1n9 13.5±0.1 
 C18:2n6 25.3±0.2 
 C18:3n3 1.4±0.1 
 C20:0 1.3±0.1 
 C20:3n3 0.397±0.001 
 C22:0 4.85±0.04 
 C22:1n9 0.643±0.04 
 C23:0 1.4±0.1 
 C24:0 5.4±0.3 
 SFA 58.3±0.2 
 MUFA 14.6±0.1 
 PUFA 27.1±0.3 
22 
 
 
Table 2. In vitro antioxidant properties of different fractions/extracts of Phellinus linteus (mean±SD)1. 
  DPPH 
scavenging  
activity  
Ferricyanide/Prussian 
blue assay  
Lipid peroxidation inhibition 
 
 
β-Carotene bleaching 
 inhibition  
TBARS formation  
Inhibition  
EC50 (µg/mL) 
Polysaccharides 340±20 b 148±1 b 1111±91 a 67±3 b 
Glucans 489±23 a 245±2 a 1103±117 a 122±5 a 
Triterpenoids 129±3 d 85±2 d 163±8 c 20.5±0.2 d 
Methanolic extract 70±2 e 50.5±0.2 e 114±1 c 8±1 e 
 Ethanolic extract 222±4 c 120±2 c 419±25 b 30±2 c 
Homoscedasticity2 p-value <0.001 <0.001 <0.001 <0.001 
One-way ANOVA3 p-value <0.001 <0.001 <0.001 <0.001 
Trolox (Standard)  43.03 ± 1.71 29.62 ± 3.15 2.63 ± 0.14 3.73 ± 1.90 
 
EC50- fraction/extract concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance for reducing power assay.  
1Different letters in each column and for each fraction/extract indicate significant differences among mean values of each EC50.  
2Homoscedasticity among fractions was tested by means of the Levene test: homoscedasticity, p-value>0.05; heteroscedasticity, p-value<0.05. 
3p<0.05 meaning that the mean value of the EC50 of at least one fraction/extract differs from the others (in this case multiple comparison tests were performed).  
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Table 3. Antibacterial activity of different fractions/extracts of Phellinus linteus (mean±SD1). 
  Staphylococcus aureus 
Bacillus 
cereus 
Micrococcus 
flavus 
Listeria 
monocytogenes 
Pseudomonas 
aeruginosa 
Salmonella 
typhimurium 
Escherichia 
coli 
Enterobacter 
cloacae 
 
 
MIC (mg/mL) 
Polysaccharides 0.18±0.02 b	   0.16±0.01 b	   0.26±0.03 b	   0.27±0.02 b	   0.17±0.02 b	   0.52±0.02 a	   0.47±0.02 b	   0.19±0.01 c	  
Glucans 0.25±0.01 a	   0.26±0.01 a	   1.4±0.1 a	   0.47±0.02 a	   0.27±0.02 a	   0.27±0.02 b	   2.2±0.2 a	   0.25±0.01 a	  
Triterpenoids 0.16±0.01 b	   0.17±0.02 b	   0.27±0.02 b	   0.27±0.02 b	   0.27±0.02 a	   0.28±0.02 b	   0.25±0.04 c	   0.23±0.02 b	  
 Methanolic extract 0.12±0.02 c	   0.032±0.002 d	   0.048±0.002 d	   0.048±0.002 c	   0.13±0.02 c	   0.095±0.003 c	   0.072±0.002 d	   0.048±0.002 e	  
 Ethanolic extract 0.10±0.01 d 0.077±0.002 c 0.15±0.01 c 0.022±0.002 d 0.047±0.002 d 0.12±0.02 c 0.17±0.02 cd 0.12±0.02 d 
Homoscedasticity2 p-value 0.049 <0.001 0.001 <0.001 0.001 0.002 <0.001 0.009 
One-way ANOVA3 p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
          
 
 
MBC (mg/mL) 
Polysaccharides 0.40±0.04 b	   0.27±0.02 b	   0.47±0.02 b	   0.47±0.02 b	   0.38±0.02 b	   1.03±0.03 b	   1.1±0.1 b	   0.43±0.02 b	  
Glucans 0.48±0.02 a	   0.48±0.02 a	   2.7±0.2 a	   1.0±0.1 a	   2.1±0.3 a	   2.1±0.3 a	   2.4±0.2 a	   2.2±0.2 a	  
Triterpenoids 0.23±0.02 c	   0.27±0.02 b	   0.52±0.02 b	   0.50±0.03 b	   0.50±0.03 b	   0.50±0.03 c	   0.52±0.02 c	   0.27±0.02 c	  
 Methanolic extract 0.19±0.01 d	   0.043±0.002 d	   0.13±0.02 c	   0.18±0.02 d	   0.17±0.02 c	   0.19±0.01 d	   0.12±0.01 d	   0.104±0.004 d	  
 Ethanolic extract 0.22±0.02 cd 0.10±0.01 c 0.18±0.02 c 0.40±0.03 c 0.12±0.02 c 0.37±0.02 c 0.23±0.02 d 0.22±0.02 cd 
Homoscedasticity2 p-value <0.001 <0.001 <0.001 0.018 <0.001 <0.001 <0.001 <0.001 
One-way ANOVA3 p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
          
MIC (mg/mL) 
Ampicillin 0.29±0.03 0.23±0.03 0.23±0.02 0.37±0.01 0.72±0.02 0.36±0.01 0.21±0.03 0.33±0.03 
Streptomycin 0.040±0.004 0.09±0.01 0.15±0.01 0.16±0.01 0.13±0.03 0.17±0.01 0.15±0.02 0.25±0.01 
MBC (mg/mL) 
Ampicillin 0.38±0.01 0.38±0.01 0.37±0.01 0.47±0.02 1.24±0.01 0.47±0.02 0.45±0.03 0.68±0.05 
Streptomycin 0.09±0.01 0.16±0.01 0.32±0.02 0.33±0.03 0.32±0.02 0.33±0.01 0.33±0.02 0.50±0.01 
MIC- minimum inhibitory concentration; MBC- minimum bactericidal concentration. 
1Different letters in each column and for each fraction/extract indicate significant differences among mean values of each MIC or each MBC.  
2Homoscedasticity among fractions/extracts was tested by means of the Levene test: homoscedasticity, p-value>0.05; heteroscedasticity, p-value<0.05. 
3p<0.05 meaning that the mean value of MIC or MBC of at least one fraction/extract differs from the others (in this case multiple comparison tests were performed).  
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Table 4. Antifungal activity of different fractions/extracts of Phellinus linteus (mean±SD1). 
  Aspergillus fumigatus 
Aspergillus 
versicolor 
Aspergillus 
ochraceus 
Aspergillus 
niger 
Trichoderma 
viride 
Penicillium 
funiculosum 
Penicillium 
ochrochloron 
Penicillium 
verrucosum 
 
 
MIC (mg/mL) 
Polysaccharides 0.51±0.04 a	   0.18±0.05 b	   0.13±0.03 c	   0.47±0.02 b	   0.27±0.02 a	   0.11±0.01 c	   0.46±0.04 a	   0.27±0.02 c	  
Glucans 0.25±0.02 c	   0.060±0.001 d	   0.12±0.01 c	   0.22±0.02 c	   0.11±0.01 bc	   0.11±0.01 c	   0.27±0.02 c	   0.27±0.02 c	  
Triterpenoids 0.24±0.04 c	   0.12±0.02 c	   0.13±0.02 c	   0.77±0.03 a	   0.10±0.01 c	   0.12±0.02 c	   0.23±0.02 d	   0.42±0.02 b	  
 Methanolic extract 0.42±0.02 b	   0.16±0.04 bc	   0.18±0.02 b	   0.74±0.04 a	   0.0045±0.0004 d	   0.20±0.01 b	   0.20±0.01 d	   0.44±0.04 b	  
 Ethanolic extract 0.39±0.03 b 0.22±0.02 a 0.22±0.02 a 0.77±0.02 b 0.12±0.02 b 0.75±0.04 a 0.35±0.03 b 0.85±0.04 a 
Homoscedasticity2 p-value <0.001 <0.001 0.002 0.022 <0.001 <0.001 0.002 0.001 
One-way ANOVA3 p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
          
 
 
MFC (mg/mL) 
Polysaccharides 1.1±0.1 a	   0.50±0.03 a	   0.46±0.03 b	   1.4±0.1 b	   0.44±0.04 a	   0.45±0.04 c	   1.0±0.1 a	   1.0±0.1 b	  
Glucans 0.47±0.02 c	   0.12±0.01 d	   0.27±0.02 c	   0.45±0.04 c	   0.26±0.02 b	   0.27±0.02 e	   0.47±0.02 c	   0.46±0.04 d	  
Triterpenoids 0.45±0.04 c	   0.44±0.03 b	   0.44±0.03 b	   1.4±0.1 b	   0.18±0.02 d	   0.85±0.04 b	   0.40±0.03 d	   0.78±0.02 c	  
 Methanolic extract 0.79±0.05 b	   0.37±0.02 c	   0.42±0.02 b	   1.4±0.1 b	   0.013±0.002 e	   0.38±0.02 d	   0.38±0.02 d	   0.77±0.02 c	  
 Ethanolic extract 0.83±0.03 b 0.43±0.02 b 0.77±0.05 a 2.2±0.2 a 0.23±0.02 c 1.4±0.1 a 0.78±0.02 b 1.4±0.1 a 
Homoscedasticity2 p-value <0.001 0.129 0.009 0.022 0.002 <0.001 0.001 <0.001 
One-way ANOVA3 p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
          
MIC (mg/mL) 
Bifonazole 0.12±0.02 0.08±0.01 0.12±0.02 0.13±0.02 0.13±0.02 0.24±0.04 0.15±0.04 0.10±0.01 
Ketoconazole 0.20±0.03 0.15±0.04 1.5±0.1 0.22±0.02 1.0±0.1 0.15±0.04 2.7±0.2 0.19±0.02 
MFC (mg/mL) 
Bifonazole 0.17±0.02 0.16±0.03 0.20±0.01 0.25±0.03 0.20±0.01 0.23±0.02 0.22±0.02 0.20±0.03 
Ketoconazole 0.49±0.01 0.44±0.04 2.2±0.2 0.52±0.02 0.8±0.2 0.52±0.05 3.6±0.1 0.30±0.03 
MIC- minimum inhibitory concentration; MFC- minimum fungicidal concentration. 
1Different letters in each column and for each fraction/extract indicate significant differences among mean values of each MIC or each MFC.  
2Homoscedasticity among fractions/extracts was tested by means of the Levene test: homoscedasticity, p-value>0.05; heteroscedasticity, p-value<0.05. 
3p<0.05 meaning that the mean value of MIC or MFC of at least one fraction/extract differs from the others (in this case multiple comparison tests were performed). 
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Table 5. Cytotoxic activity of different fractions/extracts of Phellinus linteus against human tumor cell lines and non-tumor liver primary cells 
(mean±SD1). 
  Tumor cell lines 
PLP2 
  MCF7 NCI-H460 HCT15 HeLa HepG2 
 
GI50 (µg/mL) 
Polysaccharides 221±8 c 294±3 b 208±7 b 87±4 b 97±1 e >400 
Glucans 344±6 a 349±2 a 211±1 b 202±4 a 121±5 d >400 
Triterpenoids 220±7 c 161±6 d 93±1 c 65±1 d 156±7 c >400 
Methanolic extract 283±6 b 221±9 c 261±8 a 70±3 c 373±9 a >400 
 Ethanolic extract 114±7 d 88±3 e 62±2 d 61±1 d 209±5 b >400 
Homoscedasticity2 p-value 0.485 0.003 <0.001 <0.001 0.003 - 
One-way ANOVA3 p-value <0.001 <0.001 <0.001 <0.001 <0.001 - 
        
GI50 (µg/mL) Ellipticine 0.91±0.04 1.42±0.01 1.91±0.05 1.1±0.2 3.2±0.5 2.06±0.03 
GI50- Fraction/extract concentration corresponding to 50% of growth inhibitory activity. 
1Different letters in each column and for each fraction/extract indicate significant differences among mean values of each MIC or each MFC.  
2Homoscedasticity among fractions/extracts was tested by means of the Levene test: homoscedasticity, p-value>0.05; heteroscedasticity, p-value<0.05. 
3p<0.05 meaning that the mean value of GI50 of at least one fraction/extract differs from the others (in this case multiple comparison tests were performed). 
 
 
 
 
